Barclays »

Mineralys Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $25M 654k 37.92
2025-06-30 $1.9M 144k 13.53
2025-03-31 $522k 33k 15.87
2024-12-31 $571k 46k 12.31
2024-09-30 $463k 38k 12.11
2024-06-30 $118k 10k 11.79
2024-03-31 $176k 14k 12.88
2023-12-31 $230k 27k 8.59
2023-09-30 $23k 2.5k 9.37
2023-06-30 $47k 2.8k 16.92
2023-03-31 $196k 13k 15.62